Safety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without Asthma

Clinical trial NCT01591343 · TERMINATED

Trial details

NCT number: NCT01591343
Sponsor: Laboratorios Leti, S.L.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinitis Rhinoconjunctivitis Mild Persistent Asthma Mild Intermittent Asthma

Start date: 2012-06-01
Primary completion: 2012-07-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.